CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (OP) - USD ($) $ in Thousands | 3 Months Ended |
Mar. 31, 2022 | Mar. 31, 2021 |
Operating activities: | | |
Net income | $ 79,506 | $ 52,371 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation and amortization | 84,222 | 83,420 |
Accretion of debt premium and discount, net | (716) | (725) |
Deferred financing cost amortization | 1,766 | 1,881 |
Accretion of above- and below-market leases, net | (2,971) | (2,930) |
Tenant inducement amortization and other | 1,048 | 2,071 |
Impairment of real estate assets | 4,590 | 1,467 |
Gain on sale of real estate assets | (21,911) | (5,764) |
Equity based compensation | 4,315 | 2,592 |
Loss on extinguishment of debt, net | 0 | 1,197 |
Changes in operating assets and liabilities: | | |
Receivables, net | (4,682) | 7,084 |
Deferred charges and prepaid expenses | (8,605) | (3,815) |
Other assets | (180) | (58) |
Accounts payable, accrued expenses and other liabilities | (24,122) | (28,278) |
Net cash provided by operating activities | 112,260 | 110,513 |
Investing activities: | | |
Improvements to and investments in real estate assets | (70,121) | (62,844) |
Acquisitions of real estate assets | (164,262) | (3,779) |
Proceeds from sales of real estate assets | 58,870 | 31,793 |
Purchase of marketable securities | (8,844) | (3,894) |
Proceeds from sale of marketable securities | 9,420 | 4,599 |
Net cash used in investing activities | (174,937) | (34,125) |
Financing activities: | | |
Repayment of borrowings under unsecured revolving credit facility | (115,000) | 0 |
Proceeds from borrowings under unsecured revolving credit facility | 210,000 | 0 |
Proceeds from unsecured notes | 0 | 349,360 |
Repayment of borrowings under unsecured term loans and notes | (250,000) | (350,000) |
Deferred financing and debt extinguishment costs | 0 | (3,088) |
Proceeds from issuances of OP Units | 43,871 | 0 |
Net cash used in financing activities | (194,682) | (73,791) |
Net change in cash, cash equivalents and restricted cash | (257,359) | 2,597 |
Cash, cash equivalents and restricted cash at beginning of period | 297,743 | 370,087 |
Cash, cash equivalents and restricted cash at end of period | 40,384 | 372,684 |
Reconciliation to consolidated balance sheets: | | |
Cash and cash equivalents | 31,567 | 371,402 |
Restricted cash | 8,817 | 1,282 |
Cash, cash equivalents and restricted cash at end of period | 40,384 | 372,684 |
Supplemental disclosure of cash flow information: | | |
Cash paid for interest, net of amount capitalized of $677 and $931 | 48,491 | 54,388 |
Brixmor Operating Partnership LP | | |
Operating activities: | | |
Net income | 79,506 | 52,371 |
Adjustments to reconcile net income to net cash provided by operating activities: | | |
Depreciation and amortization | 84,222 | 83,420 |
Accretion of debt premium and discount, net | (716) | (725) |
Deferred financing cost amortization | 1,766 | 1,881 |
Accretion of above- and below-market leases, net | (2,971) | (2,930) |
Tenant inducement amortization and other | 1,048 | 2,071 |
Impairment of real estate assets | 4,590 | 1,467 |
Gain on sale of real estate assets | (21,911) | (5,764) |
Equity based compensation | 4,315 | 2,592 |
Loss on extinguishment of debt, net | 0 | 1,197 |
Changes in operating assets and liabilities: | | |
Receivables, net | (4,682) | 7,084 |
Deferred charges and prepaid expenses | (8,605) | (3,815) |
Other assets | (180) | (58) |
Accounts payable, accrued expenses and other liabilities | (24,122) | (28,278) |
Net cash provided by operating activities | 112,260 | 110,513 |
Investing activities: | | |
Improvements to and investments in real estate assets | (70,121) | (62,844) |
Acquisitions of real estate assets | (164,262) | (3,779) |
Proceeds from sales of real estate assets | 58,870 | 31,793 |
Purchase of marketable securities | (8,844) | (3,894) |
Proceeds from sale of marketable securities | 9,420 | 4,599 |
Net cash used in investing activities | (174,937) | (34,125) |
Financing activities: | | |
Repayment of borrowings under unsecured revolving credit facility | (115,000) | 0 |
Proceeds from borrowings under unsecured revolving credit facility | 210,000 | 0 |
Proceeds from unsecured notes | 0 | 349,360 |
Repayment of borrowings under unsecured term loans and notes | (250,000) | (350,000) |
Deferred financing and debt extinguishment costs | 0 | (3,088) |
Proceeds from issuances of OP Units | 43,871 | 0 |
Partner distributions and repurchases of OP Units | (74,923) | (70,063) |
Net cash used in financing activities | (186,052) | (73,791) |
Net change in cash, cash equivalents and restricted cash | (248,729) | 2,597 |
Cash, cash equivalents and restricted cash at beginning of period | 282,585 | 360,073 |
Cash, cash equivalents and restricted cash at end of period | 33,856 | 362,670 |
Reconciliation to consolidated balance sheets: | | |
Cash and cash equivalents | 25,039 | 361,388 |
Restricted cash | 8,817 | 1,282 |
Cash, cash equivalents and restricted cash at end of period | 33,856 | 362,670 |
Supplemental disclosure of cash flow information: | | |
Cash paid for interest, net of amount capitalized of $677 and $931 | $ 48,491 | $ 54,388 |